Cardiome Pharma Corp.
Cardiome Announces Next Steps for GED-aPC Asset and Transition of Dr. Charles Fisher to Consulting Role
Published in Medical Verdicts and Law Weekly, October 15th, 2009
Cardiome Pharma Corp. (NASDAQ:CRME)(NASDAQ:/)(NASDAQ:TSX:)(NASDAQ:COM) announced the decision that future development and commercialization of its GED-aPC technology, currently held in a subsidiary company, will be funded externally from Cardiome. In support of the transition of the GED-aPC program, Dr. Charles Fisher, Chief Medical Officer and Executive Vice President, Clinical Regulatory Affairs, will assume an advisory role as a consultant to Cardiome, effective October 1, 2009. It is expected that the GED-aPC subsidiary will seek external capital to fund future activities. Cardiome may choose to co-invest in the venture to maintain its equity interest.
"We want to...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
More Articles from Medical Verdicts and Law Weekly
- AAA Michigan; Michigan Deer Crash Coalition
Vehicle-Deer Crash Coalition Unveils New Website - AARP Idaho
AARP Says 'No Way' to No Social Security COLA in 2010 - Acacia Research Corporation
Acacia Subsidiary Enters into License Agreement with Covidien PLC - Aging
LifeVantage Announces Fourth Quarter and Fiscal Year 2009 Financial and Operating Results - AirTran Airways
AirTran Airways Becomes the Official Airline of the Orlando Magic - Alexza Pharmaceuticals, Inc.
Alexza to Raise $19.7 Million in Private Placement - More from this issue of Medical Verdicts and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
